These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3912922)
41. Immunological bone marrow purging procedure in Burkitt's lymphoma. Evaluation by a liquid cell culture assay. Favrot MC; Philip I; Maritaz O; Garçon N; Philip T Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):455-62. PubMed ID: 3912923 [No Abstract] [Full Text] [Related]
42. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies. De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552 [TBL] [Abstract][Full Text] [Related]
43. High sensitivity and specificity assay for detection of leukemia/lymphoma cells in human bone marrow. Bregni M; Siena S; Dalla-Favera R; Gianni AM Ann N Y Acad Sci; 1987; 511():473-82. PubMed ID: 3125782 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil. Reiner P; Mardiak J; Reinerová M; Ujházy V Neoplasma; 1981; 28(5):533-9. PubMed ID: 6947140 [TBL] [Abstract][Full Text] [Related]
46. Autotransplantation after in vitro immunotherapy of lymphoblastic leukemia. Wells JR; Billing R; Herzog P; Feig SA; Gale RP; Terasaki P; Cline MJ Exp Hematol; 1979; 7 Suppl 5():164-9. PubMed ID: 400684 [TBL] [Abstract][Full Text] [Related]
47. Relevance of colony forming assays to bone marrow transplanation with particular reference to grafting for aplastic anaemia. Gordon MY Br J Haematol; 1979 May; 42(1):61-71. PubMed ID: 37884 [TBL] [Abstract][Full Text] [Related]
48. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies. Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454 [TBL] [Abstract][Full Text] [Related]
49. Elimination of T-lymphocytes from human bone marrow with monoclonal T-antibodies and cytolytic complement. Granger S; Janossy G; Francis G; Blacklock H; Poulter LW; Hoffbrand AV Br J Haematol; 1982 Feb; 50(2):367-74. PubMed ID: 6977374 [TBL] [Abstract][Full Text] [Related]
50. [In vitro separation of bone marrow nuclear cells with methylcellulose and its application to autologous bone marrow transplantation in patients with leukemia]. Bai H; Da WM; Dong GP Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):103-5. PubMed ID: 8070289 [TBL] [Abstract][Full Text] [Related]
51. Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies. Ball ED; Vredenburgh JJ; Mills LE; Cornwell GG; Schwarz L; Howell AL; Troy K Bone Marrow Transplant; 1990 Oct; 6(4):277-80. PubMed ID: 1982228 [TBL] [Abstract][Full Text] [Related]
52. Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia. Körbling M; Knauf W; Funderud S; Kvalheim G; Hunstein W Haematologica; 1991 Mar; 76 Suppl 1():29-36. PubMed ID: 1650742 [TBL] [Abstract][Full Text] [Related]
53. Bone marrow purging from malignant cells. Dicato M; Heiser D; Kadusch L Bull Soc Sci Med Grand Duche Luxemb; 1985; 122(1):5-7. PubMed ID: 3899393 [No Abstract] [Full Text] [Related]
54. In vitro treatment of bone marrow from patients with T-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma using the immunotoxin WT1-ricin A. Barnett MJ; Rohatiner AZ; Kingston JE; Adams KE; Batten EL; Bassan R; Thorpe PE; Horton MA; Malpas JS; Lister TA Haematol Blood Transfus; 1987; 31():57-8. PubMed ID: 3327786 [No Abstract] [Full Text] [Related]
55. Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation. Ball ED; Howell AL J Cell Biochem; 1988 Apr; 36(4):445-52. PubMed ID: 3288649 [TBL] [Abstract][Full Text] [Related]
56. Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557). LeBien TW; Anderson JM; Vallera DA; Uckun FM Leuk Res; 1986; 10(2):139-43. PubMed ID: 3951251 [TBL] [Abstract][Full Text] [Related]
57. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Treleaven JG; Gibson FM; Ugelstad J; Rembaum A; Philip T; Caine GD; Kemshead JT Lancet; 1984 Jan; 1(8368):70-3. PubMed ID: 6140424 [TBL] [Abstract][Full Text] [Related]
60. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts. Uckun FM; Stong RC; Youle RJ; Vallera DA J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]